NeuroMetrix is an innovation-driven company focused on the development and global commercialization of non-invasive medical devices for the diagnosis and treatment of pain and neurological disorders. The company is located in Woburn, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. NeuroMetrix markets the following products: DPNCheck® is an automated, fast, accurate, and quantitative nerve conduction test used to evaluate peripheral neuropathies. It is designed to be used by clinicians at the point-of-care to objectively detect, stage, and monitor peripheral neuropathies. Please visit at www.dpncheck.com. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of entrapment neuropathies. Please visit www.advancencs.com. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain. The Company is also developing prescription applications using the Quell technology platform. Please visit www.QuellRelief.com.
External link for NeuroMetrix, Inc.
4b Gill St
Woburn, Massachusetts 01801, US
NeuroMetrix, Inc. reposted this
How do you treat nociplastic pain? Seeking a drug-free option without major side effects? Quell Fibromyalgia is the first and only FDA authorized medical device that helps reduce the symptoms of fibromyalgia. Stop by our booth #313 at PAINWeek or visit our website: https://bit.ly/4dNixsZ to learn more. #PAINWeek2024 #PAINWeek #quellfibromyalgia #dpncheck
Come check out DPNCheck at PAINWeek! Learn how early detection of peripheral neuropathy uncovers risk for neuropathic pain, falls, and foot ulcers, which can lead to hospitalizations and amputations if not managed appropriately. Don't miss a chance to connect with our very own SVP of Population Health & Value Based Care, Susan Bell RN, BN. #PAINWeek #PAINWeek2024 #dpncheck #peripheralneuropathy #neuropathicpain
Join us at our booth at PAINWeek to discover how Quell Fibromyalgia's innovative, drug-free, wearable technology is opening the door to a new way to manage fibromyalgia. PLUS, see the Company's innovative DPNCheck device; a fast, accurate and easy-to-use quantitative test to detect peripheral neuropathies earlier. #PAINWeek2024 #PAINWeek #quellfibromyalgia #dpncheck NeuroMetrix, Inc.
Quell Fibromyalgia is excited to be heading back to Las Vegas for this year’s PAINWeek conference. Stop by Quell Fibromyalgia’s booth #313 to learn about the first and only medical device to receive FDA authorization to help reduce the symptoms of #fibromyalgia. #PAINWeek2024 #PAINWeek #quellfibromyalgia NeuroMetrix, Inc. #dpncheck
Fibromyalgia affects millions of people with debilitating symptoms that can affect their quality of life on a daily basis. Today, on Fibromyalgia Awareness Day, please join us as we raise awareness and support those living with this complex and often misunderstood health condition. To learn more about how Quell Fibromyalgia helps reduce symptoms in patients with fibromyalgia and high pain sensitivity visit our website: https://bit.ly/44Ug2BP #NeuroMetrix #QuellFibromyalgia #fibromyalgia #FibromyalgiaAwarenessDay
Did you know that since January 2023, DPNCheck has been featured in no fewer than twelve peer-reviewed publications? See the rapidly growing body of research that investigates or leverages our easy-to-use handheld nerve conduction test here: https://bit.ly/3vs7VPo Interested in using DPNCheck measurements in your own research? Learn more about the advantages of using DPNCheck in clinical trials: https://bit.ly/4cv0QOK #ClinicalResearch #ClinicalTrials #Diabetes #DiabetesResearch #PeripheralNeuropathy
Hayashi et al recently published findings in The Journal of Diabetes Investigation demonstrating that DPNCheck's point-of-care nerve conduction study could accurately predict the severity of peripheral neuropathy in patients with diabetes (DPN). “The use of DPNCheck and electrocardiogram would make the diagnosis of DPN simple, ubiquitous, and with high reproducibility and reliability.” (read more) #Diabetes #DiabetesCare #DiabetesManagement #PeripheralNeuropathy #DPN #NCS #Neurology
NeuroMetrix, Inc. reposted this
And that's a wrap! Thank you RISE for a fantastic conference. So happy to connect with friends and colleagues at one the best gatherings of the year. Special thanks to John Romans of Biomedix and Dr. Shannon I. Decker, PhD., MBA, MBA, M.Ed., M.Ed. for sharing their insights and expertise to help drive better patient outcomes. #RISENational2024
PRESS RELEASE: NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral Neuropathy https://bit.ly/3PqgOzJ "The use of DPNCheck and electrocardiogram would make the diagnosis of DPN simple, ubiquitous, and with high reproducibility and reliability." - Hayashi et al “The consistently high accuracy of DPNCheck stands in stark contrast to monofilament testing, which has been the standard approach to DPN screening despite its low accuracy and reliability” - Shai Gozani, CEO NeuroMetrix, Inc. #Diabetes #DiabetesCare #DiabetesManagement #PeripheralNeuropathy #DPN #NCS #Neurology
Headed to RISE National in Nashville this weekend? NeuroMetrix, Inc. will be there! Connect with Brandi Damkier, our very own VP of Clinical Partnerships. Learn how a simple DPNCheck test at the point of care can help healthcare providers detect and defend against some of the most dangerous complications of #Diabetes. https://bit.ly/4cfBT9L #EarlyDetection #RiseNational2024 #ValueBasedCare #DiabetesCare #PeripheralNeuropathy #Nephropathy #Retinopathy #CKD #medicareadvantage